Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Sindh Institute of Urology and Transplantation

🇵🇰Pakistan

Country: 🇵🇰Pakistan

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease Patients

Not Applicable

Not yet recruiting

Conditions: Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease

Interventions: Drug: Ferric Carboxymaltose (FCM)
Drug: Iron Sucrose injection

First Posted Date: 2025-05-29

Last Posted Date: 2025-05-29

Lead Sponsor: Sindh Institute of Urology and Transplantation

Target Recruit Count: 128

Registration Number: NCT06994065

Locations: 🇵🇰
Sindh Institute of Urology and Transplantaion, Karachi, Sindh, Pakistan

Permanent Celiac Plexus Block: Comparison of Pain Score in Unilateral and Bilateral Posterior Percutaneous Approach

Phase 4

Completed

Conditions: Abdominal Cancer
Cancer Pain
Cancer of Pancreas

Interventions: Drug: Unilateral Neurolytic Celiac Plexus Block with Absolute Alcohol
Drug: Bilateral Neurolytic Celiac Plexus Block with Absolute Alcohol

First Posted Date: 2024-03-19

Last Posted Date: 2024-03-19

Lead Sponsor: Sindh Institute of Urology and Transplantation

Target Recruit Count: 30

Registration Number: NCT06316908

Locations: 🇵🇰
Sindh Institute of Urology and Transplantation, Karachi, Sindh, Pakistan

Dexmedetomidine Versus Ketofol for Moderate Sedation in Endoscopic Retrograde Cholangiopancreatography

Phase 4

Completed

Conditions: Sedation

Interventions: Drug: Ketofole
Drug: Dexmedetomidine

First Posted Date: 2024-01-18

Last Posted Date: 2024-01-18

Lead Sponsor: Sindh Institute of Urology and Transplantation

Target Recruit Count: 62

Registration Number: NCT06212401

Locations: 🇵🇰
Sindh Institute of Urology and Transplantation, Karachi, Sindh, Pakistan

Comparison Between Sevoflurane and Propofol for Maintenance of Sedation During ERCP

Phase 4

Completed

Conditions: Sedation Complication

Interventions: Drug: Propofol 1 % Injectable Suspension
Drug: Sevoflurane

First Posted Date: 2023-08-18

Last Posted Date: 2023-08-18

Lead Sponsor: Sindh Institute of Urology and Transplantation

Target Recruit Count: 86

Registration Number: NCT05996588

Locations: 🇵🇰
Syed Muhammad Abbas, Karachi, Sindh, Pakistan

Effects of Intrathecal Dexmedetomidine as an Adjuvant to Low Dose Hyperbaric 0.5% Bupivacaine

Phase 4

Completed

Conditions: Post Operative Pain

Interventions: Drug: Bupivacain 0.5%
Drug: Dexmedetomidine Hydrochloride

First Posted Date: 2023-08-16

Last Posted Date: 2023-10-31

Lead Sponsor: Sindh Institute of Urology and Transplantation

Target Recruit Count: 108

Registration Number: NCT05993975

Locations: 🇵🇰
Syed Muhammad Abbas, Karachi, Sindh, Pakistan

Comparison of Efficacy of Bupivacaine in Supraclavicular Block With or Without Dexmedetomidine

Phase 4

Completed

Conditions: Pain

Interventions: Other: saline
Drug: DEXmedetomidine

First Posted Date: 2023-08-14

Last Posted Date: 2023-08-14

Lead Sponsor: Sindh Institute of Urology and Transplantation

Target Recruit Count: 108

Registration Number: NCT05991375

Locations: 🇵🇰
Syed Muhammad Abbas, Karachi, Sindh, Pakistan

Comparison Between Bupivacaine and Bupivacaine With Dexmedetomidine in Caudal Block for Post Operative Pain Control

Phase 4

Completed

Conditions: Post Operative Pain

Interventions: Drug: Bupivacaine Hydrochloride 0.25% Injection plus Dexmedetomidine 1 microgram/kg body weight
Drug: Bupivacaine Hydrochloride 0.25% Injection Solution

First Posted Date: 2023-06-26

Last Posted Date: 2023-07-11

Lead Sponsor: Sindh Institute of Urology and Transplantation

Target Recruit Count: 60

Registration Number: NCT05919173

Locations: 🇵🇰
Sindh Institute of Urology and Transplantation. Department of Anaesthesia and Surgical Intensive Care Units, Karachi, Sindh, Pakistan

Attenuation Of Hemodynamic Response To Laryngoscopy. Role Of Dexmedetomidine. A Dose Finding Study

Phase 4

Completed

Conditions: Hemodynamic Instability
Tracheal Intubation
Dexmedetomidine

Interventions: Drug: Normal saline
Drug: Dexmedetomidine 0.75 microgram/kg
Drug: Dexmedetomidine 0.5 microgram/kg

First Posted Date: 2023-06-18

Last Posted Date: 2023-06-18

Lead Sponsor: Sindh Institute of Urology and Transplantation

Target Recruit Count: 105

Registration Number: NCT05909215

Locations: 🇵🇰
Syed Muhammad Abbas, Karachi, Sindh, Pakistan

Exploring the Risk Factors for Colorectal Cancer in Our General Population Using Asian Pacific Screening Score: a Survey From Pakistan

Completed

Conditions: Colorectal Cancer
Colorectal Neoplasms

First Posted Date: 2022-11-15

Last Posted Date: 2024-04-22

Lead Sponsor: Sindh Institute of Urology and Transplantation

Target Recruit Count: 558

Registration Number: NCT05617378

Locations: 🇵🇰
Sindh Institute of Urology and Transplantation, Karachi, Sindh, Pakistan

The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study

Completed

Conditions: Breast Cancer Invasive
Breast Cancer
Breast Cancer Stage
Breast Neoplasms
Breast Cancer Metastatic

First Posted Date: 2022-07-18

Last Posted Date: 2022-07-21

Lead Sponsor: Sindh Institute of Urology and Transplantation

Target Recruit Count: 690

Registration Number: NCT05463276

Locations: 🇵🇰
Sindh Institute of Urology and Transplantation, Karachi, Sindh, Pakistan

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy